3,5,3′-Triiodo-L-thyronine enhances the differentiation of a human pancreatic duct cell line (hPANC-1) towards a β-cell-like phenotype

Journal of Cellular Physiology

Volumn 204, Issue 1, 2005, Pages 286-296

  Misiti, Silvia ^a,b   Anastasi, Emanuela ^a   Sciacchitano, Salvatore ^a,b   Falzacappa, Cecilia Verga ^a,b   Panacchia, Laura ^a,b   Bucci, Barbara ^b   Khouri, Daniele ^b   D'Acquarica, Ilaria ^a   Brunetti, Ercole ^b   Di Mario, Umberto ^a   Toscano, Vincenzo ^a,b   Perfetti, Riccardo ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; GLUCOSE TRANSPORTER 2; INSULIN; LIOTHYRONINE; MESSENGER RNA;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INSULIN SYNTHESIS; PANCREAS DUCT; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL;

CARCINOMA, PANCREATIC DUCTAL; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 2; HUMANS; INSULIN; ISLETS OF LANGERHANS; MONOSACCHARIDE TRANSPORT PROTEINS; PANCREATIC NEOPLASMS; PHENOTYPE; RECEPTORS, THYROID HORMONE; TRIIODOTHYRONINE; UP-REGULATION;

EID: 20144380224     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20293     Document Type: Article

References (34)

1. Anastasi E, Ponte E, Gradini R, Bulotta A, Sale P, Tiberti C, Okamoto H, Dotta F, Di Mario U. 1999. Expression of Reg and cytokeratin 20 during ductal cell differentiation and proliferation in a mouse model of autoimmune diabetes. Eur J Endocrinol 141(6):644-652.
2. Bech K, Damsbo P, Eldrup E, Beck-Nielsen H, Roder ME, Hartling SG, Volund A, Madsbad S. 1996. β-cell function and glucose and lipid oxidation in Graves' disease. Clinical Endocrinology (Oxford) 44(1):59-66.
3. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, O'Neil JJ. 2000. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97(14):7999-8004.
4. Campbell SC, Macfarlane WM. 2002. Regulation of the Pdx1 gene promoter in pancreatic β-cells. BBRC 299:277-284.
5. Clark AR, Wilson ME, London NJ, James RF, Docherty K. 1995. Identification and characterization of a functional retinoic acid/thyroid hormone response element upstream of the human insulin gene enhancer. Biochemical Journal 309(pt3):863-870.
6. Coffman FD, Studzinski GP. 1999. Differentiation-related mechanisms which suppress DNA replication. Exper Cell Res 248:58-73.
7. Cortizo AM, Chazenbalk GD, de Gagliardino EE, Garcia ME, Pisarev MA, Gagliardino JJ. 1987. Thyroid hormone binding and deiodination by pancreatic islets: Relationship with the in vitro effect upon insulin secretion. Acta Endocrinol (Copenh) 116:66-72.
8. D'Agnano I, Valentini A, Fornari C, Bucci B, Starace G, Felsani A, Citro G. 2001. Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27 kip1 levels. Oncogene 20:2814-2825.
9. Edlund H. 2002. Pancreatic organogenesis developmental mechanisms and implication for therapy. Nat Rev Genet 3:524-532.
10. Guz Y, Nasir I, Teitelman G. 2001. Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology 142(11):4956-4968.
11. Halvorsen T, Levine F. 2001. Diabetes mellitus-cell transplantation and gene therapy approaches. Curr Mol Med 1(2):273-286.
12. Hardikar AA, Wang XY, Williams LJ, Kwok J, Wong R, Yao M, Tuch BE. 2002. Functional maturation of fetal porcine beta-cells by glucagon-like peptide 1 and cholecystokinin. Endocrinology 143(9):3505-3514.
13. Hardikar AA, Marcus-Samuels B, Geras-Raaka E, Raaka BM, Gershengorn MC. 2003. Human pancreatic precursor cells secrete FGP2 to stimulate clustering into hormone-expressing islet-like cell aggregates. Proc Natl Acad Sci USA 100:7117-7122.
14. Hui H, Perfetti R. 2002. Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur J Endocrinol 146:129-141.
15. Hui H, Wright C, Perfetti R. 2001. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 50:785-796.
16. Ikeda T, Fujiyama K, Hoshino T, Takeuchi T, Mashiba H, Tominaga M. 1990. Oral and intravenous glucose-induced insulin secretion in hyperthyroid patients. Metabolism 39(6):633-637.
17. Koizumi M, Doi R, Toyoda E, Masui T, Tulachan SS, Kawaguchi Y, Fujimoto K, Gittes GK, Imamura M. 2003. Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery 134:260-266.
18. Lebel JM, Dussault JH, Puymirat J. 1994. Overexpression of the β1 thyroid receptor induces differentiation in Neuro-2a cells. Proc Natl Acad Sci USA 91:2644-2648.
19. Lee JT, Lebenthal E, Lee PC. 1989. Rat pancreatic nuclear thyroid hormone receptor: Characterization and postnatal development. Gastroenterology 96:1151-1157.
20. Li M, Miyagawa J, Yamamoto K, Moriwaki M, Imagawa A, Iwahashi H, Yamagata K, Tochino Y, Hanafusa T, Matsuzawa Y. 2002. Beta cell heogenesis from ducts and phenotypic conversion of residual islet cells in the adult pancreas of glucose intolerant mice induced by selective alloxan perfusion. Endocr J 49(5):561-572.
21. Macfarlane WM, Smith SB, James RFL, Clifton AD, Doza YN, Cohen P, Docherty K. 1997. The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor1 and insulin gene transcription by high glucose in pancreatic β-cells. J Biol Chem 272:20936-20944.
22. Ohguni S, Notsu K, Kato Y. 1995. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Grave's disease. Intern Med 34(5):339-341.
23. Oppenheimer JH, Schwartz HL, Surks MI. 1974. Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: Liver, kidney, pituitary, heart, brain, spleen and testis. Endocrinology 95:897-903.
24. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. 2000. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 6(3):278-282.
25. Shapiro AM, Ryan EA, Lakey JR. 2001. Clinical islet transplant-state of the art. Transplant Proc 33(7-8):3502-3503.
26. Shi YB, Brown DD. 1990. Developmental and thyroid hormone-dependent regulation of pancreatic genes in Xenopus laevis. Genes and Development 4:1107-1113.
27. Siebler T, Robson H, Shalet SM, Williams GR. 2002. Dexamethasone inhibits and thyroid hormone promotes differentiation of mouse chondrogenic ATDC5 cells. Bone 31(4):457-464.
28. Slack JMW. 1995. Developmental biology of the pancreas. Development 121: 1569-1580.
29. SoHa B. 2001. In vitro differentiation of pancreatic beta cells. Differentiation 68:205-219.
30. Valcana T, Timiras PS. 1978. Nuclear triiodothyronine receptors in the developing rat brain. Endocrinology 11:31-41.
31. Wang Y, Perfetti R, Greig NH, Holloway HW, De Ore KA, Montrose-Rafizadeh C, Elahi D, Egan JM. 1997. Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J Clin Invest 99:2883-2889.
32. Yamada T, Shirota T, Aizawa T, Takasu N. 1991. Blood glucose, serum thyroid hormones, insulin, C-peptide and C-peptide/insulin ratio in hyperthyroid patients. Horm Metab Res 23(10):504-505.
33. Yen PM. 2001. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81(3):1097-1142.
34. Zhou J, Pineyro MA, Wang X, Doyle ME, Egan JM. 2002. Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: Involvement of PDX-1 and HNF3β transcription factors. J Cellular Physiol 192:304-314.